Furthermore, the clinicopathological factors of HCC patients with or without HBc E77, S87 and P156 mutation were compared (Table S2), and patients with the E77 mutation displayed higher AST levels and larger tumour size. The gene discussed is KRT88P; the disease is hepatocellular carcinoma.